Labcorp Earns IVDR CE-Marking for PGDx elio™ tissue complete, Paving the Way for Expanded Personalized Oncology Testing Across Europe In a milestone achievement that advances the accessibility of precision oncology in Europe, Labcorp (NYSE: LH), a global leader in comprehensive…
Simulations Plus and Polish Academy Scientists Validate AI-Powered Drug Design Models in Breakthrough Discovery Targeting Inflammation and Immune Regulation Simulations Plus, Inc. (Nasdaq: SLP), a prominent developer of modeling and simulation software for the biopharmaceutical industry, in collaboration with the…
Centauri Therapeutics Secures Additional $5.1M from CARB-X to Propel Lead Antibacterial Candidate ABX-01 Into First-in-Human Trials Centauri Therapeutics Limited, an innovative immunotherapy company leveraging a novel platform for combating infectious diseases, announced today it has been awarded an additional $5.1…
Flatiron Health Triples Global Oncology Research Network to Power Multinational Real-World Evidence Generation Flatiron Health, a healthtech company pioneering the use of real-world data (RWD) to transform cancer care and accelerate oncology research, has announced a significant milestone: the tripling…
Aptar’s Nasal Delivery System Helps Validate Breakthrough Alzheimer’s Treatment in Wake Forest Study In a major advancement for Alzheimer’s research and the evolving field of drug delivery science, AptarGroup, Inc. (NYSE: ATR), a global leader in the design and manufacturing…
CVS Health Unveils New Workforce Innovation and Talent Center in Columbus to Empower Local Communities Through Job Training and Health Services In a powerful step toward strengthening community health and economic resilience, CVS Health® (NYSE: CVS) has officially opened the…
ReAlta Life Sciences Publishes Preclinical Data Showing RLS-0071 Reduces Brain Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy Model ReAlta Life Sciences, Inc., a clinical-stage biopharmaceutical company advancing therapies that rebalance the body’s inflammatory response, has announced the publication of new preclinical findings…
Takeda Gains FDA 510(k) Clearance for HyHub™ and HyHub™ Duo to Enhance HYQVIA® Administration Experience for Patients with Primary Immunodeficiency and CIDP Takeda (TSE:4502/NYSE:TAK), a global biopharmaceutical leader, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)…
WHO Strongly Condemns Attacks on Staff Shelter and Warehouse in Gaza as Humanitarian Health Operations Reach Breaking Point The World Health Organization (WHO) has issued a forceful condemnation of recent assaults on its facilities and staff in Deir al Balah,…
PolyActiva Strengthens Executive Team to Accelerate U.S. Expansion and Advance Late-Stage Clinical Development of Sustained-Release Ocular Therapies PolyActiva, a clinical-stage biopharmaceutical company at the forefront of innovation in ocular drug delivery, has announced two key leadership appointments that signal a…
Tempus Secures FDA 510(k) Clearance for AI-Driven ECG-Low EF Software, Expanding Capabilities in Cardiovascular Risk Detection Tempus AI, Inc. (NASDAQ: TEM), a trailblazer in applying artificial intelligence to drive precision medicine forward, has reached a significant milestone in the cardiology…
Veranex Launches Industry’s First Innovation CRO to Accelerate MedTech R&D in a Tight Capital Climate Veranex, a global leader in integrated product development and contract research services for medical technology, has officially launched the industry’s first Innovation CRO (iCRO) —…